Tag #Personalized Medicine

Showing 49 to 52 of 52 results

parma.repubblica.it

🌐 75% Global Worthiness

Dec 10, 22:09

€400,000 Grant Funds Multi-Omic Leukemia Therapy Research at University of Parma

The University of Parma's Translational Hematology and Chemogenomics group received a €400,000 grant to develop personalized therapies for high-risk acute leukemias using a multi-omic model integrating genomic, proteomic, and metabolic data, led by Giovanni Roti in collaboration with Alessio Lodola.

€400,000 Grant Funds Multi-Omic Leukemia Therapy Research at University of Parma

The University of Parma's Translational Hematology and Chemogenomics group received a €400,000 grant to develop personalized therapies for high-risk acute leukemias using a multi-omic model integrating genomic, proteomic, and metabolic data, led by Giovanni Roti in collaboration with Alessio Lodola.

Progress

8% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the collaboration between the hematology and drug design experts contribute to the project's success?

The LDRscreen project, a collaboration between Giovanni Roti and Alessio Lodola, leverages advanced technologies in rational drug design. It will develop new platforms for drug repositioning and identify therapeutic targets via genomic, proteomic, and metabolic analysis. This aligns with the THEC's mission to translate academic research into precision medicine.

pda.kp.ru

🌐 85% Global Worthiness

Dec 1, 19:16

Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials

Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...

Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials

Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the vaccine be used in clinical trials, and what are the plans for future research directions?

The Gamaleya Institute is developing a personalized mRNA vaccine against melanoma that targets both the primary tumor and metastases. Successful preclinical results indicate potential for treating various cancers, including lung, kidney, and brain cancers, although further research is needed.

bari.repubblica.it

🌐 90% Global Worthiness

Dec 9, 19:09

World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer

A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...

World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer

A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of this world-first treatment for urinary tract cancer at Bari's Policlinico?

At Bari's Policlinico hospital, a 75-year-old woman with high-risk urinary tract cancer received a world-first treatment: a personalized mRNA vaccine (cevumeran) combined with nivolumab immunotherapy following surgery. The mRNA vaccine targets specific tumor mutations, boosting the immune system's attack on cancer cells. This innovative approach offers hope beyond conventional chemotherapy, which has limited efficacy and high toxicity.

bbc.com

🌐 75% Global Worthiness

Nov 23, 22:54

Four Types of Aging: How to Determine Your Type and Maintain Youth and Health

Scientists have identified four types of biological aging, each affecting different bodily systems. Understanding your aging type allows for personalized health interventions to slow down aging and improve longevity.

Four Types of Aging: How to Determine Your Type and Maintain Youth and Health

Scientists have identified four types of biological aging, each affecting different bodily systems. Understanding your aging type allows for personalized health interventions to slow down aging and improve longevity.

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the four main types of biological aging identified in the study?

The article discusses four types of biological aging identified by scientists: metabolic, immune, hepatic, and nephrotic aging. These types are characterized by the accelerated deterioration of specific bodily systems.

Showing 49 to 52 of 52 results